Cantitate/Preț
Produs

Coronaviruses and other Novel Antiviral Targets: Annual Reports in Medicinal Chemistry, cartea 57

Katherine Seley-Radtke
en Limba Engleză Hardback – 17 noi 2021
Annual Reports in Medicinal Chemistry, Volume 57 in this long-running series, highlights new advances in the field with this new volume presenting interesting chapters on the Mechanism of action of the broadly acting antiviral drug remdesivir, Improving properties of the nucleobase analogue T-706 as a potential anti-SARS-CoV-2 and anti-influenza compound, Antivirals for RNA virus infections Anno 2020-2021, Broad spectrum antiviral fleximer nucleosides, SARS-CoV-2 main protease inhibitors, The search for antivirals to treat alphavirus infections, Inhibitors of Ebola Virus targeting Innate immune evasion, Uracil derivatives as non-nucleoside inhibitors of viral infections, and more.


  • Provides the authority and expertise of leading contributors from an international board of authors
  • Presents the latest release in the Annual Reports in Medicinal Chemistry
  • Updated release includes the latest information on the Coronaviruses and other novel antiviral targets
Citește tot Restrânge

Din seria Annual Reports in Medicinal Chemistry

Preț: 79215 lei

Preț vechi: 110762 lei
-28% Nou

Puncte Express: 1188

Preț estimativ în valută:
15162 15802$ 12621£

Carte tipărită la comandă

Livrare economică 30 decembrie 24 - 13 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780323915113
ISBN-10: 0323915116
Pagini: 254
Dimensiuni: 152 x 229 mm
Greutate: 0.51 kg
Editura: ELSEVIER SCIENCE
Seria Annual Reports in Medicinal Chemistry


Public țintă

Undergraduates, graduates, academics, and researchers in the field of medicinal chemistry

Cuprins

1. Improving properties of the nucleobase analogs T-705/T-1105 as potential antivirals
2. Anno 2021: Which antivirals for the coming decade?
3. Broad spectrum antiviral fleximer nucleosides
4. The search for antivirals to treat alphavirus infections
5. Inhibitors of Ebola Virus targeting Innate immune evasion
6. Uracil derivatives as non-nucleoside inhibitors of viral infections